Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Burlingame, California.

BrainStorm Cell Therapeutics Ltd., a subsidiary of Brainstorm Cell Therapeutics, Inc., is a company headquartered in Israel that develops adult stem cell therapeutic products.\nThe company says this about itself: BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The Company holds the rights to clinical development and commercialization of the NurOwn® technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug designation status from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm has completed a Phase 3 pivotal trial in ALS (NCT03280056); this trial investigated the safety and efficacy of repeat-administration of autologous MSC-NTF cells and was supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989). BrainStorm completed under an investigational new drug application a Phase 2 open-label multicenter trial (NCT03799718) of autologous MSC-NTF cells in progressive multiple sclerosis (MS) and was supported by a grant from the National MS Society (NMSS).

Part of Pluri, Inc., Pluristem Ltd. is a company headquartered in Haifa, Israel, that provides research and development services in the biotechnology field, especially in stem cell research. The firm was founded by Yoram Nathan Drucker. Pluri, Inc. acquired Pluristem Ltd. on June 23, 2003.

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.

Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA.

Qingdao Aoke Biological Development Co., Ltd., established on 2003-07-17, Business scope includes cord blood preservation and development research;Technology development of cell engineering related products;Development of Cell Series Technology Engineering;cell therapy technology,cell antibody,Technology development of gene medicine;Research and development of biological reagents,Sales(Does not contain drugs,medical instruments,dangerous goods);Immune Cells,umbilical cord,placenta,Adipose stem cell preservation and development research(Clinical application of stem cell transplantation technology not included);Production,wholesale,retail cosmetics;medical service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Global Cord Blood Corp., Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. (doing business as Tianhe Nuoya Bio-engineering Co., Ltd.) is a company headquartered in Guangzhou, China, that provides cord blood banking services.

Ciri Stem Cell Technology Co., Ltd., established on 2014-05-13, Business scope includes stem cells,biopharmaceutical products,Technology development for genetic testing,technology transfer,Technical Services,technical consulting;Stem Cell Storage Technology Services;Enterprise Management Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK.

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Tongren Fantel Biotechnology Co., Ltd., established on 2015-05-26, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(medical products,biological products,cosmetic,health care(Function)food,Green food and other products related to health,Health Management Consulting and Services,stem cell storage,Production of traditional Chinese medicine drinks,Sales,food processing agent,Plant lease.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments))

Guangdong Chuangsheng Holding Group Co., Ltd., established on 2007-01-04, Business scope includes general items:Corporate Headquarters Management;Engage in investment activities with own funds;Domestic trade agent;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Socioeconomic Advisory Services;property management;real estate consulting;Real estate brokerage;Information Consulting Service(Not including licensing information consulting services);Financial Advisory;Machinery and Equipment Leasing;furniture sales;food sales(Only sell prepackaged food);General merchandise sales;Daily necessities sales;Wholesale of hardware products;Hardware retail;Bazaar management services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Tobacco retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Nanjing Leyang Pharmaceutical Technology Co., Ltd., established on 2019-04-18, Business scope includes research and development of medical technology,Technical Services;Chemical Products,Research and development of medicinal capsules,Sales;medicine,Sales of laboratory instruments and consumables;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)